Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)

NCT06193928 is registered in ClinicalTrials.gov with Mirum Pharmaceuticals, Inc. as lead sponsor.

NCT NCT06193928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06193928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
Lead sponsor
Mirum Pharmaceuticals, Inc.
Phase
Observational
Overall status
Recruiting
Start date
September 21, 2023
Completion date
September 20, 2030
Enrollment
70 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

alagille syndrome, progressive familial intrahepatic cholestasis